|
Form 4 Filings | Insider Buys | Significant Buys |
Penny Stocks Insider Buying |
Insider Sales |
| Insider Buy Sell Ratios | Stock Options |
Insider Trading Top Lists |
Insider Trading Graph View |
Insider Watch |
|
|
"Insiders might sell their shares for any number of reasons, but they buy them for only one:
they think the price will rise" - Peter Lynch ==>> What is insider trading>> |

| Transaction & Date | Reported Date |
Company | Symbol | Insider Relationship |
Shares Traded | Average Price | Total Amount |
Shares Ownership |
Filing |
| 2006-03-17 Purchase |
2006-03-20 5:53 pm | DUSA PHARMACEUTICALS INC | DUSA | SHULMAN D GEOFFREY (Chairman of the Board & CEO Director) | 5,000 | $6.67 | $33,350 | 87,668 (Direct) | View |
| Transaction & Date |
Reported Date |
Company | Symbol | Insider Relationship | Shares Traded | Average Price |
Total Amount |
Shares Ownership |
Filing |
| 2008-05-09 Option Award |
2008-05-13 1:36 pm | DUSA PHARMACEUTICALS INC | DUSA | SHULMAN D GEOFFREY (Chairman of the Board & Director Chief Strategic Officer) | 11,000 | $0 | $0 | 11,000 (Direct) |
View |
| 2004-07-14 Exercise | 2004-07-14 7:07 pm |
DUSA PHARMACEUTICALS INC | DUSA | SHULMAN D GEOFFREY (President and CEO Director) | 25,000 | $4.69 | $117,250 | 82,668 (Direct) | View |
| 2004-02-17 Exercise | 2004-02-18 09:42 am | DUSA PHARMACEUTICALS INC | DUSA | SHULMAN D GEOFFREY (President and CEO Director) | 10,000 | $6.5 | $65,000 | 57,668 (Direct) |
View |
| Transaction & Date |
Reported Date | Exercisable Expiration |
Company | Symbol | Insider Relationship |
Shares Traded | Conversion Price |
Shares Ownership | Filing |
| 2008-05-09 Option Award | 2008-05-13 1:36 pm | 2009-05-09 2015-05-09 | DUSA PHARMACEUTICALS INC | DUSA | SHULMAN D GEOFFREY (Chairman of the Board & Director Chief Strategic Officer) | 16,500 | $2.2 | 16,500 (Direct) | View |
| 2007-03-20 Option Award | 2007-03-21 1:34 pm | 2008-03-20 2014-03-20 |
DUSA PHARMACEUTICALS INC | DUSA | SHULMAN D GEOFFREY (Chairman of the Board & CEO Director) | 75,000 | $3.37 | 1,150,000 (Direct) |
View |
| 2006-10-18 Other | 2006-10-19 2:50 pm | 2006-10-18 2011-01-29 | DUSA PHARMACEUTICALS INC | DUSA | SHULMAN D GEOFFREY (Chairman of the Board & CEO Director) | 250,000 | $6 | 250,000 (Direct) |
View |
| 2006-03-27 Option Award | 2006-03-29 12:28 pm | 2007-03-27 2016-03-26 |
DUSA PHARMACEUTICALS INC | DUSA | SHULMAN D GEOFFREY (Chairman of the Board & CEO Director) | 55,000 | $6.75 | 55,000 (Direct) |
View |
| 2005-06-30 Option Award |
2005-07-01 12:55 pm | 2005-06-30 2015-06-29 |
DUSA PHARMACEUTICALS INC | DUSA | SHULMAN D GEOFFREY (Chairman of the Board & CEO Director) | 10,000 | $9.3 | 10,000 (Direct) |
View |
| 2005-03-17 Option Award |
2005-03-21 11:11 am |
N/A 2015-03-16 |
DUSA PHARMACEUTICALS INC | DUSA | SHULMAN D GEOFFREY (Chairman of the Board & CEO Director) | 80,000 | $10 | 80,000 (Direct) |
View |
| 2004-07-14 Exercise |
2004-07-14 7:07 pm |
N/A 2004-08-02 | DUSA PHARMACEUTICALS INC | DUSA | SHULMAN D GEOFFREY (President and CEO Director) | 10,000 | $4.69 | 0 (Direct) |
View |
| 2004-07-14 Exercise | 2004-07-14 7:07 pm | N/A 2004-08-02 | DUSA PHARMACEUTICALS INC | DUSA | SHULMAN D GEOFFREY (President and CEO Director) | 15,000 | $4.69 | 0 (Direct) |
View |
| 2004-06-30 Option Award |
2004-07-01 12:31 pm | 2004-06-30 2014-06-29 |
DUSA PHARMACEUTICALS INC | DUSA | SHULMAN D GEOFFREY (President and CEO Director) | 10,000 | $9.5 | 10,000 (Direct) | View |
| 2004-03-18 Option Award |
2004-03-22 11:18 am | N/A 2014-03-18 |
DUSA PHARMACEUTICALS INC | DUSA | SHULMAN D GEOFFREY (President and CEO Director) | 100,000 | $9.92 | 100,000 (Direct) | View |
| 2004-02-17 Exercise | 2004-02-18 09:42 am |
1995-02-16 2004-02-17 |
DUSA PHARMACEUTICALS INC | DUSA | SHULMAN D GEOFFREY (President and CEO Director) | 10,000 | $6.5 | 0 (Direct) | View |
|
© 2005-2008 SecForm4.Com All rights reserved. Archives: 2008 2007 2006 2005 2004 2003 Sun, 23 Nov 2008 04:25:10 -0600 |
SEC is the U.S. Securities and Exchange Commission. EDGAR is a trademark of the SEC. SecForm4.Com is not affiliated with or approved by the U.S. Securities and Exchange Commission (SEC). Terms of Use | Privacy Statement | |